|
Volumn 57, Issue 4, 2001, Pages 663-671
|
Deep brain stimulation in the treatment of Parkinson's disease: A cost-effectiveness analysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMANTADINE;
CARBIDOPA;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
LEVODOPA;
PRAMIPEXOLE;
ROPINIROLE;
SELEGILINE;
ADULT;
ARTICLE;
BRAIN DEPTH STIMULATION;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
HEALTH CARE COST;
HEALTH ECONOMICS;
HUMAN;
MAJOR CLINICAL STUDY;
PARKINSON DISEASE;
PRIORITY JOURNAL;
QUALITY ADJUSTED LIFE YEAR;
QUALITY OF LIFE;
SCORING SYSTEM;
SENSITIVITY AND SPECIFICITY;
STATISTICAL ANALYSIS;
|
EID: 0035964267
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.57.4.663 Document Type: Article |
Times cited : (100)
|
References (25)
|